|
2025-04-29 |
2025-04-29 |
B
Purchase
|
Massaro Joseph R
Non-Executive Director
|
1,000
+30.1%
12.30
USD 99,630
|
1,000
+30.1%
|
12.30
|
USD 100,000
|
|
|
2025-04-29 |
2025-04-28 |
B
Purchase
|
Kang Lan
Non-Executive Director
|
1,000
+16.5%
12.57
USD 62,850
|
1,000
+16.5%
|
12.57
|
USD 100,000
|
|
|
2025-04-29 |
2025-04-28 |
B
Purchase
|
SUMME GREGORY L
Non-Executive Director
|
1,000
+inf%
12.50
USD 312,500
|
1,000
+inf%
|
12.50
|
USD 100,000
|
|
|
2025-04-29 |
2025-04-28 |
B
Purchase
|
Peacock Jonathan M
Non-Executive Director
|
1,000
+4.2%
12.81
USD 103,646
|
1,000
+4.2%
|
12.81
|
USD 100,000
|
|
|
2025-02-28 |
2025-02-27 |
S
Sale
|
Bramwell James
EVP Sales, Customer Excellence
Officer
|
774
-0.9%
17.00
USD 13,158
|
774
-0.9%
|
17.00
|
USD 13,158
|
|
|
2025-02-28 |
2025-02-27 |
S
Sale
|
Eck Steven W
SVP & Chief Accounting Officer
Officer
|
1,033
-2.5%
17.00
USD 17,561
|
1,033
-2.5%
|
17.00
|
USD 17,561
|
|
|
2025-02-28 |
2025-02-26 |
S
Sale
|
Bramwell James
EVP Sales, Customer Excellence
Officer
|
3,758
-4.1%
17.53
USD 65,878
|
3,758
-4.1%
|
17.53
|
USD 65,878
|
|
|
2025-02-28 |
2025-02-26 |
S
Sale
|
Eck Steven W
SVP & Chief Accounting Officer
Officer
|
4,907
-10.8%
17.53
USD 86,020
|
4,907
-10.8%
|
17.53
|
USD 86,020
|
|
|
2024-09-06 |
2024-09-05 |
S
Sale
|
Eck Steven W
SVP & Chief Accounting Officer
Officer
|
3,525
-10.7%
25.06
USD 88,337
|
3,525
-10.7%
|
25.06
|
USD 88,337
|
|
|
2024-08-01 |
2024-07-31 |
S
Sale
|
Couturier Christophe
EVP, AMEA
Officer
|
100
-0.1%
28.00
USD 2,800
|
100
-0.1%
|
28.00
|
USD 2,800
|
|
|
2024-08-01 |
2024-07-30 |
PS
Planned sale
|
Couturier Christophe
EVP, AMEA
Officer
|
10,000
-11.9%
27.00
USD 270,000
|
10,000
-11.9%
|
27.00
|
USD 270,000
|
|
|
2024-03-12 |
2024-03-08 |
PS
Planned sale
|
Eck Steven W
SVP & Chief Accounting Officer
Officer
|
3,685
-9.7%
25.63
USD 94,447
|
3,685
-9.7%
|
25.63
|
USD 94,447
|
|
|
2024-03-01 |
2024-02-29 |
S
Sale
|
Couturier Christophe
EVP, AMEA
Officer
|
13,074
-13.5%
24.53
USD 320,705
|
13,074
-13.5%
|
24.53
|
USD 320,705
|
|
|
2024-03-01 |
2024-02-29 |
S
Sale
|
Bramwell James
EVP Sales, Customer Excellence
Officer
|
4,910
-4.9%
24.52
USD 120,393
|
4,910
-4.9%
|
24.52
|
USD 120,393
|
|
|
2024-02-27 |
2024-02-27 |
S
Sale
|
Bramwell James
EVP Sales, Customer Excellence
Officer
|
6,203
-5.8%
24.49
USD 151,911
|
6,203
-5.8%
|
24.49
|
USD 151,911
|
|
|
2023-09-07 |
2023-09-07 |
S
Sale
|
Eck Steven W
SVP & Chief Accounting Officer
Officer
|
7,577
-21.2%
20.64
USD 156,389
|
7,577
-21.2%
|
20.64
|
USD 156,389
|
|
|
2023-08-28 |
2023-08-25 |
S
Sale
|
Vanderhaegen Frederic
EVP, Americas and Europe
Officer
|
25,000
-13.5%
21.47
USD 536,750
|
25,000
-13.5%
|
21.47
|
USD 536,750
|
|
|
2023-04-13 |
2023-04-11 |
S
Sale
|
Couturier Christophe
EVP, AMEA
Officer
|
1,498
-1.5%
21.18
USD 31,728
|
1,498
-1.5%
|
21.18
|
USD 31,728
|
|
|
2023-03-06 |
2023-03-03 |
PS
Planned sale
|
Brophy Gerard
EVP, Biopharma Production
Officer
|
3,914
-3.5%
25.00
USD 97,850
|
3,914
-3.5%
|
25.00
|
USD 97,850
|
|
|
2023-03-01 |
2023-02-28 |
PS
Planned sale
|
Couturier Christophe
EVP, AMEA
Officer
|
2,324
-2.3%
24.32
USD 56,520
|
2,324
-2.3%
|
24.32
|
USD 56,520
|
|
|
2023-03-01 |
2023-02-27 |
PS
Planned sale
|
Brophy Gerard
EVP, Biopharma Production
Officer
|
3,059
-2.6%
25.00
USD 76,475
|
3,059
-2.6%
|
25.00
|
USD 76,475
|
|
|
2023-02-27 |
2023-02-23 |
PS
Planned sale
|
Couturier Christophe
EVP, AMEA
Officer
|
3,078
-3.2%
24.24
USD 74,611
|
3,078
-3.2%
|
24.24
|
USD 74,611
|
|
|
2023-02-22 |
2023-02-22 |
PS
Planned sale
|
Couturier Christophe
EVP, AMEA
Officer
|
19,160
-16.5%
24.12
USD 462,139
|
19,160
-16.5%
|
24.12
|
USD 462,139
|
|
|
2023-02-02 |
2023-02-02 |
PS
Planned sale
|
Brophy Gerard
EVP, Biopharma Production
Officer
|
11,339
-10.0%
25.06
USD 284,155
|
11,339
-10.0%
|
25.06
|
USD 284,155
|
|
|
2022-11-17 |
2022-11-16 |
B
Purchase
|
Szlosek Thomas A
EVP & CFO
Officer
|
12,500
+54.0%
20.71
USD 258,850
|
12,500
+54.0%
|
20.71
|
USD 258,850
|
|
|
2022-11-17 |
2022-11-16 |
B
Purchase
|
Stubblefield Michael
CEO
Executive Director
|
15,000
+3.6%
20.95
USD 314,250
|
15,000
+3.6%
|
20.95
|
USD 314,250
|
|
|
2022-05-23 |
2022-05-23 |
S
Sale
|
Vanderhaegen Frederic
EVP, Americas & Europe
Officer
|
39,000
-23.5%
31.61
USD 1,232,790
|
39,000
-23.5%
|
31.61
|
USD 1,232,790
|
|
|
2022-05-23 |
2022-05-20 |
PS
Planned sale
|
Brophy Gerard
EVP, Biopharma Production
Officer
|
19,603
-16.8%
31.27
USD 612,986
|
19,603
-16.8%
|
31.27
|
USD 612,986
|
|
|
2022-03-02 |
2022-03-01 |
PS
Planned sale
|
Brophy Gerard
EVP, Biopharma Production
Officer
|
2,027
-1.5%
34.47
USD 69,871
|
2,027
-1.5%
|
34.47
|
USD 69,871
|
|
|
2022-02-25 |
2022-02-23 |
PS
Planned sale
|
Brophy Gerard
EVP, Biopharma Production
Officer
|
3,059
-2.4%
33.79
USD 103,364
|
3,059
-2.4%
|
33.79
|
USD 103,364
|
|
|
2022-01-05 |
2022-01-05 |
PS
Planned sale
|
Brophy Gerard
EVP, Biopharma Production
Officer
|
11,551
-8.1%
38.65
USD 446,446
|
11,551
-8.1%
|
38.65
|
USD 446,446
|
|
|
2022-01-05 |
2022-01-03 |
PS
Planned sale
|
Brophy Gerard
EVP, Biopharma Production
Officer
|
59,418
-29.4%
40.77
USD 2,422,472
|
59,418
-29.4%
|
40.77
|
USD 2,422,472
|
|
|
2021-12-23 |
2021-12-22 |
PS
Planned sale
|
Couturier Christophe
EVP, AMEA
Officer
|
28,125
-20.3%
41.53
USD 1,168,031
|
28,125
-20.3%
|
41.53
|
USD 1,168,031
|
|
|
2021-12-23 |
2021-12-21 |
PS
Planned sale
|
Couturier Christophe
EVP, AMEA
Officer
|
38,309
-25.7%
41.00
USD 1,570,669
|
38,309
-25.7%
|
41.00
|
USD 1,570,669
|
|
|
2021-12-10 |
2021-12-09 |
PS
Planned sale
|
Couturier Christophe
EVP, AMEA
Officer
|
7,859
-6.6%
40.24
USD 316,246
|
7,859
-6.6%
|
40.24
|
USD 316,246
|
|
|
2021-12-10 |
2021-12-08 |
PS
Planned sale
|
Couturier Christophe
EVP, AMEA
Officer
|
5,828
-5.0%
40.00
USD 233,120
|
5,828
-5.0%
|
40.00
|
USD 233,120
|
|
|
2021-12-03 |
2021-12-01 |
PS
Planned sale
|
GUPTA RAJIV
Non-Executive Director
|
100,000
-10.2%
39.30
USD 3,930,000
|
100,000
-10.2%
|
39.30
|
USD 3,930,000
|
|
|
2021-11-15 |
2021-11-12 |
S
Sale
|
Vanderhaegen Frederic
EVP, Europe
Officer
|
80,000
-34.1%
38.25
USD 3,060,000
|
80,000
-34.1%
|
38.25
|
USD 3,060,000
|
|
|
2021-11-15 |
2021-11-11 |
PS
Planned sale
|
Vanderhaegen Frederic
EVP, Europe
Officer
|
60,804
-28.2%
38.41
USD 2,335,482
|
60,804
-28.2%
|
38.41
|
USD 2,335,482
|
|
|
2021-11-02 |
2021-11-01 |
PS
Planned sale
|
GUPTA RAJIV
Non-Executive Director
|
100,000
-9.3%
40.31
USD 4,031,000
|
100,000
-9.3%
|
40.31
|
USD 4,031,000
|
|
|
2021-10-04 |
2021-10-01 |
PS
Planned sale
|
GUPTA RAJIV
Non-Executive Director
|
100,000
-8.5%
39.94
USD 3,994,000
|
100,000
-8.5%
|
39.94
|
USD 3,994,000
|
|
|
2021-09-02 |
2021-09-01 |
PS
Planned sale
|
GUPTA RAJIV
Non-Executive Director
|
100,000
-7.8%
39.45
USD 3,945,000
|
100,000
-7.8%
|
39.45
|
USD 3,945,000
|
|
|
2021-07-13 |
2021-07-09 |
PS
Planned sale
|
Bramwell James
EVP, Strategic Partners
Officer
|
12,221
-12.4%
35.64
USD 435,556
|
12,221
-12.4%
|
35.64
|
USD 435,556
|
|
|
2021-07-13 |
2021-07-09 |
PS
Planned sale
|
Bramwell James
EVP, Strategic Partners
Officer
|
6,110
-5.9%
35.56
USD 217,272
|
6,110
-5.9%
|
35.56
|
USD 217,272
|
|
|
2021-06-29 |
2021-06-28 |
PS
Planned sale
|
Couturier Christophe
EVP, AMEA
Officer
|
28,096
-20.3%
35.73
USD 1,003,870
|
28,096
-20.3%
|
35.73
|
USD 1,003,870
|
|
|
2021-06-28 |
2021-06-25 |
PS
Planned sale
|
GUPTA RAJIV
Non-Executive Director
|
68,605
-4.7%
35.32
USD 2,423,129
|
68,605
-4.7%
|
35.32
|
USD 2,423,129
|
|
|
2021-06-10 |
2021-06-10 |
PS
Planned sale
|
Stubblefield Michael
President and CEO
Executive Director
|
57,375
-3.9%
32.48
USD 1,863,540
|
57,375
-3.9%
|
32.48
|
USD 1,863,540
|
|
|
2021-06-10 |
2021-06-10 |
PS
Planned sale
|
Stubblefield Michael
President and CEO
Executive Director
|
42,512
-2.9%
32.48
USD 1,380,790
|
42,512
-2.9%
|
32.48
|
USD 1,380,790
|
|
|
2021-06-10 |
2021-06-09 |
PS
Planned sale
|
Stubblefield Michael
President and CEO
Executive Director
|
235,170
-14.4%
32.03
USD 7,532,495
|
235,170
-14.4%
|
32.03
|
USD 7,532,495
|
|
|
2021-06-10 |
2021-06-08 |
PS
Planned sale
|
Stubblefield Michael
President and CEO
Executive Director
|
152,643
-9.8%
32.04
USD 4,890,682
|
152,643
-9.8%
|
32.04
|
USD 4,890,682
|
|
|
2021-05-28 |
2021-05-27 |
S
Sale
|
GUPTA RAJIV
Non-Executive Director
|
78,109
-21.9%
31.94
USD 2,494,801
|
78,109
-21.9%
|
31.94
|
USD 2,494,801
|
|
|
2021-05-28 |
2021-05-27 |
S
Sale
|
Ohri Devashish
EVP, IMEA
Officer
|
100,000
-41.8%
31.99
USD 3,199,000
|
100,000
-41.8%
|
31.99
|
USD 3,199,000
|
|
|
2021-05-28 |
2021-05-26 |
S
Sale
|
GUPTA RAJIV
Non-Executive Director
|
150,000
-29.6%
31.89
USD 4,783,500
|
150,000
-29.6%
|
31.89
|
USD 4,783,500
|
|
|
2021-05-27 |
2021-05-26 |
S
Sale
|
Ohri Devashish
EVP, IMEA
Officer
|
15,000
-9.7%
31.87
USD 478,050
|
15,000
-9.7%
|
31.87
|
USD 478,050
|
|
|
2021-05-26 |
2021-05-24 |
S
Sale
|
GUPTA RAJIV
Non-Executive Director
|
157,571
-23.7%
31.57
USD 4,974,516
|
157,571
-23.7%
|
31.57
|
USD 4,974,516
|
|
|
2021-05-26 |
2021-05-24 |
S
Sale
|
GUPTA RAJIV
Non-Executive Director
|
180,000
-21.3%
31.74
USD 5,713,200
|
180,000
-21.3%
|
31.74
|
USD 5,713,200
|
|
|
2021-05-25 |
2021-05-24 |
S
Sale
|
Ohri Devashish
EVP, IMEA
Officer
|
9,124
-6.2%
31.75
USD 289,687
|
9,124
-6.2%
|
31.75
|
USD 289,687
|
|
|
2021-05-21 |
2021-05-20 |
PS
Planned sale
|
Miller Justin
EVP & General Counsel
Officer
|
18,488
-17.6%
31.12
USD 575,347
|
18,488
-17.6%
|
31.12
|
USD 575,347
|
|
|
2021-05-21 |
2021-05-20 |
PS
Planned sale
|
Brophy Gerard
EVP, Biopharma Production
Officer
|
19,603
-11.6%
31.10
USD 609,653
|
19,603
-11.6%
|
31.10
|
USD 609,653
|
|
|
2021-04-13 |
2021-04-12 |
PS
Planned sale
|
Bramwell James
EVP, Strategic Partners
Officer
|
2,505
-2.1%
32.00
USD 80,160
|
2,505
-2.1%
|
32.00
|
USD 80,160
|
|
|
2021-04-13 |
2021-04-12 |
PS
Planned sale
|
Miller Justin
EVP & General Counsel
Officer
|
100,000
-45.7%
33.21
USD 3,321,000
|
100,000
-45.7%
|
33.21
|
USD 3,321,000
|
|
|
2021-04-13 |
2021-04-12 |
PS
Planned sale
|
Miller Justin
EVP & General Counsel
Officer
|
2,895
-2.4%
31.75
USD 91,916
|
2,895
-2.4%
|
31.75
|
USD 91,916
|
|
|
2021-04-13 |
2021-04-12 |
PS
Planned sale
|
Ohri Devashish
EVP, IMEA
Officer
|
100,160
-39.1%
32.37
USD 3,242,179
|
100,160
-39.1%
|
32.37
|
USD 3,242,179
|
|
|
2021-03-10 |
2021-03-09 |
S
Sale
|
Vanderhaegen Frederic
EVP, Europe
Officer
|
10,000
-3.9%
28.21
USD 282,100
|
10,000
-3.9%
|
28.21
|
USD 282,100
|
|
|
2021-03-03 |
2021-03-02 |
S
Sale
|
Wondrasch Michael
EVP & CIO
Officer
|
3,036
-2.0%
28.71
USD 87,164
|
3,036
-2.0%
|
28.71
|
USD 87,164
|
|
|
2021-02-26 |
2021-02-24 |
PS
Planned sale
|
Brophy Gerard
EVP, Biopharma Production
Officer
|
3,059
-1.7%
27.93
USD 85,438
|
3,059
-1.7%
|
27.93
|
USD 85,438
|
|
|
2021-02-23 |
2021-02-22 |
PS
Planned sale
|
Brophy Gerard
EVP, Biopharma Production
Officer
|
19,769
-10.1%
28.62
USD 565,789
|
19,769
-10.1%
|
28.62
|
USD 565,789
|
|
|
2021-02-08 |
2021-02-05 |
S
Sale
|
Wondrasch Michael
EVP & CIO
Officer
|
40,000
-22.0%
29.77
USD 1,190,800
|
40,000
-22.0%
|
29.77
|
USD 1,190,800
|
|
|
2021-02-08 |
2021-02-05 |
PS
Planned sale
|
Wondrasch Michael
EVP & CIO
Officer
|
9,468
-6.3%
29.77
USD 281,862
|
9,468
-6.3%
|
29.77
|
USD 281,862
|
|
|
2021-01-13 |
2021-01-11 |
PS
Planned sale
|
Brophy Gerard
EVP, Biopharma Production
Officer
|
162,248
-47.6%
30.04
USD 4,873,930
|
162,248
-47.6%
|
30.04
|
USD 4,873,930
|
|
|
2021-01-13 |
2021-01-11 |
PS
Planned sale
|
Brophy Gerard
EVP, Biopharma Production
Officer
|
216,332
-54.8%
30.08
USD 6,507,267
|
216,332
-54.8%
|
30.08
|
USD 6,507,267
|
|
|
2021-01-13 |
2021-01-11 |
PS
Planned sale
|
Bramwell James
EVP, Strategic Partners
Officer
|
2,505
-2.1%
30.00
USD 75,150
|
2,505
-2.1%
|
30.00
|
USD 75,150
|
|
|
2021-01-08 |
2021-01-06 |
PS
Planned sale
|
Brophy Gerard
EVP, Biopharma Production
Officer
|
11,509
-6.1%
27.24
USD 313,505
|
11,509
-6.1%
|
27.24
|
USD 313,505
|
|
|
2021-01-06 |
2021-01-04 |
PS
Planned sale
|
Brophy Gerard
EVP, Biopharma Production
Officer
|
59,418
-23.8%
27.84
USD 1,654,197
|
59,418
-23.8%
|
27.84
|
USD 1,654,197
|
|
|
2020-12-23 |
2020-12-21 |
PS
Planned sale
|
Bramwell James
EVP, Strategic Partners
Officer
|
10,020
-7.8%
27.14
USD 271,943
|
10,020
-7.8%
|
27.14
|
USD 271,943
|
|
